Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens (Q38306977)

2 September 2017

Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens (English)

1 reference

2 September 2017

Kate H Gartlan

3

0 references

Richard Flavell

object named as

Richard A Flavell

8

0 references

Quentin J Sattentau

9

object named as

Quentin J Sattentau

1 reference

2 September 2017

Neil C Sheppard

1

1 reference

2 September 2017

Sarah A Brinckmann

2

1 reference

2 September 2017

Manoj Puthia

4

1 reference

2 September 2017

Catharina Svanborg

5

1 reference

2 September 2017

George Krashias

6

1 reference

2 September 2017

Stephanie C Eisenbarth

7

1 reference

2 September 2017

Frank Wegmann

10

1 reference

2 September 2017

20 May 2014

1 reference

2 September 2017

International Immunology

1 reference

2 September 2017

26

1 reference

2 September 2017

10

1 reference

2 September 2017

531-538

1 reference

The perfect mix: recent progress in adjuvant research

2 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Design and gene delivery activity of modified polyethylenimines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Polyethylenimine-based non-viral gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Materials engineering for immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

The role of antibodies in HIV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Nonviral gene delivery vectors use syndecan-dependent transport mechanisms in filopodia to reach the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Induction of immunity to human immunodeficiency virus type-1 by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Tumor targeting with surface-shielded ligand--polycation DNA complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

The Nalp3 inflammasome is essential for the development of silicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Mechanism of action of clinically approved adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Improved antigen cross-presentation by polyethyleneimine-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Innate signaling networks in mucosal IgA class switching

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXU055

21 January 2018

Identifiers

DOI

10.1093/INTIMM/DXU055

1 reference

2 September 2017

1 reference